Invitation to Asarina Pharma R&D Day 2020
Asarina Pharma invites institutional investors, financial analysts and media to join its R&D day, focused on the upcoming Study results in the company's lead indication PMDD.Date: March 26, 2020 Time: 14.00-17.00, registration from 13.30 Location: Helio GT30, Grev Turegatan 30, Stockholm With presentations from PMDD practitioners and patients, as well as Asarina Pharma’s leading researchers and managers, the day will give a broad picture of PMDD, what the most meaningful clinical effects for a treatment are, and how the company's upcoming Phase IIb data will be evaluated and